Sign in

CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company

ACHIEVE LIFE SCIENCES, INC.

Sign in to watch
Ticker
ACHV
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
954343413
Phone
425-686-1500
Business address
22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
Former names
ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
  1. 8-K Event Results of operations · Executive or director change
  2. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  3. 10-K/A Report 10-K/A
  4. SCHEDULE 13D Stake Beneficial Ownership Report
  5. 3 Insider Initial Statement of Ownership
  6. SCHEDULE 13G Stake Statement of Beneficial Ownership
  7. SCHEDULE 13D Stake Beneficial Ownership Report
  8. 3 Insider Initial Statement of Ownership
  9. 3 Insider Initial Statement of Ownership
  10. SCHEDULE 13G Stake Statement of Beneficial Ownership
  11. SCHEDULE 13G Stake Statement of Beneficial Ownership
  12. 4 Derivatives Options or other derivatives
  13. 3 Insider Initial Statement of Ownership
  14. 8-K Event Material agreement · Unregistered share sale · Executive or director change · Regulation FD disclosure
  15. S-8 Other Securities Offered to Employees in Benefit Plans
  16. S-8 Other Securities Offered to Employees in Benefit Plans
  17. 10-K Report Annual Report
  18. 8-K Event Results of operations
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 3 of 68 · 1,358 filings